We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoarrays Advance Biologic Detection

By Biotechdaily staff writers
Posted on 21 May 2002
New nanoarrays of proteins with features more than 1,000 times smaller than those used in conventional arrays can yield more information more accurately in a shorter period of time. More...
These nanoarrays have more than one million times the density of current commercial microarrays, say the developers.

The new detection technology, developed by researchers at Northwestern University (Evanston, IL, USA), was reported in the online February 7, 2002, issue of Science. The researchers invented a process called Dip-pen Nanolithography to make the nanoarrays, which allowed them to use an atomic force microscope tip as a nano-pen to write out a tiny protein array on a gold surface. With an array of protein dots as small as 100 nanometers in diameter, the gold surface in between the dots was processed to prevent it from absorbing target proteins and disturbing the readings. When an array on a chip was exposed to protein targets in solution, the protein on the substrate bound its complementary proteins. The atomic force microscope then read the chip and recorded a match where a change in height was detected.

Current technology uses arrays of either proteins or DNA on the micrometer level as screening tools for analyzing DNA, protein-protein interactions, cell biology, and drug testing. Miniaturizing these arrays should dramatically improve their capabilities. The researchers say the new arrays could lead to the next generation of proteomic arrays and new methods of diagnosing infectious diseases, including portable devices that could be used in a doctor's office to rapidly screen for diseases or in the field to detect biologic weapons.

"Creating patterns on a submicrometer level is important,” said Chad A. Mirkin, director of Northwestern's Institute for Nanotechnology and a professor of chemistry. "More detailed questions can be asked and answered when working on the nanometer scale. This is a fundamental advance in biorecognition.”



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
All-in-One Molecular System
AIO M160
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.